Protez Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Protez Pharmaceuticals Ownership

Who owns Protez Pharmaceuticals?

Protez Pharmaceuticals is owned by Novartis AG. It was acquired on June 4, 2008.

Was Protez Pharmaceuticals formerly PE-backed?

Yes. Protez Pharmaceuticals was formerly owned by 3 private investors.

Protez Pharmaceuticals Business Overview

Where is Protez Pharmaceuticals headquartered?

Protez Pharmaceuticals is headquartered in Malvem, Pennsylvania.

What sector is Protez Pharmaceuticals in?

Protez Pharmaceuticals is a life science company.

When was Protez Pharmaceuticals founded?

Protez Pharmaceuticals was founded in 2003.

Life Science M&A Summary in 2008

Out of 60 sectors in the Mergr database, life science ranked 10 in number of deals in 2008. The largest life science acquisition in 2008 was Alpharma Pharmaceuticals - which was acquired by King Pharmaceuticals for $16.0B.

Join Mergr to view all 128 acquisitions of life science companies in 2008, including 24 acquisitions by private equity firms, and 104 by strategics.

Protez Pharmaceuticals, Inc.

30 Spring Mill Drive,
Malvem, Pennsylvania 19355
United States,
(610) 695-0200
www.protez.com

Protez Pharmaceuticals, Inc. is a drug development company focused on novel antibiotics for the hospital market. Key program areas for Protez include a breakthrough broad spectrum carbapenem and two combination strategies for product line extensions of multiple established antibiotics.


 Subscribe to unlock this and 202,314
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.